Asia shares pare gains on caution, oil falls again
Asia stocks reversed early gains on Tuesday, with traders sidelined ahead of U.S. inflation data and a European monetary policy meeting this week while oil prices lost more ground on worries over the fragile state of the global recovery.
Big Biogen boost on Alzheimer’s news could win back biotech investors
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer’s disease could reinvigorate investor interest more broadly in biotech and pharmaceutical shares that have struggled in 2021.
U.S. approval of Biogen Alzheimer’s drug sends shares soaring, hailed as ‘big day” for patients
U.S. regulators on Monday approved Biogen Inc’s (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.
